Cardinal Health announced that DuraBlue Sterilization Wrap received Food and Drug Administration (FDA) clearance for STERRAD NX and STERRAD 100NX Systems from Advanced Sterilization Products (ASP). The wrap also received FDA clearance for 180-day extended sterility maintenance indications for each 510(k)-cleared sterilization modality. The clearances separate the Cardinal Health DuraBlue Sterilization Wrap from alternative wraps. DuraBlue Sterilization Wrap is now the only dual-layered sterilization wrap in the U.S. market cleared by the FDA for current ASP STERRAD Systems modalities. It is also the only dual-layer wrap in the U.S. market where the entire product line has longer-than-30-day sterility maintenance indications for all highly utilized sterilization modalities. Sterilization wrap is critical for the productive use of reusable sur gical instruments, because it enables the effective sterilization of enclosed medical devices and maintains their sterility during storage and transport.
For more information, visit www.cardinalhealth.com